J2720 HCPCS Level II code: Injection, protamine sulfate, per 10 mg
J2720 is the HCPCS code for “Injection, protamine sulfate, per 10 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J2720Injection, protamine sulfate, per 10 mg
Short description: Inj protamine sulfate/10 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J2720 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 1982
Where J2720 sits
- 1J codesDrugs administered other than orally
- 2Active code J2720Injection, protamine sulfate, per 10 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J2720 mean?
J2720 is the HCPCS code for “Injection, protamine sulfate, per 10 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J2720?
CMS lists J2720’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J2720
All J codesJ2680Injection, fluphenazine decanoate, up to 25 mgJ2690Injection, procainamide hcl, up to 1 gmJ2700Injection, oxacillin sodium, up to 250 mgJ2704Injection, propofol, 10 mgJ2710Injection, neostigmine methylsulfate, up to 0.5 mgJ2711Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mgJ2724Injection, protein c concentrate, intravenous, human, 10 iuJ2725Injection, protirelin, per 250 mcgJ2730Injection, pralidoxime chloride, up to 1 gmJ2760Injection, phentolamine mesylate, up to 5 mgJ2765Injection, metoclopramide hcl, up to 10 mgJ2770Injection, quinupristin/dalfopristin, 500 mg (150/350)